CBIO Crescent Biopharma, Inc.
Fundamentals / CIK 0001253689 / USDCrescent Biopharma, Inc. reported $15.00M in revenue and a net loss of $109.1M for the trailing twelve months ended September 30, 2026, with a -1216.6% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CBIO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$15.00M Sep 30, 2026
-
Operating Income TTM-$182.5M -1216.6% margin
-
Net Income TTM-$109.1M -727.6% net margin
-
Diluted EPS TTM-- Split-adjusted
-
Free Cash Flow TTM-$82.43M -549.5% FCF margin
-
Cash & ST Investments Sep 30, 2026$289.4M Total debt: $2.46M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.84M | -- | $10K | $75K | $1.16M | $10.16M | -- | -- | -- | $18K |
| Research & Development | $138.1M | $14.26M | $20.07M | $28.39M | $47.49M | $44.93M | $47.03M | $40.09M | $24.10M | $23.28M |
| Total Operating Expenses | $163.5M | $40.04M | $39.29M | $47.48M | $64.61M | $61.67M | $61.39M | $51.50M | $33.93M | $31.93M |
| Operating Income | -$152.6M | -$40.04M | -$39.28M | -$47.40M | -$63.45M | -$51.51M | -$61.39M | -$51.50M | -$33.93M | -$31.91M |
| EBITDA | -$152.5M | -$40.00M | -$39.12M | -$47.20M | -$63.18M | -$51.24M | -$61.11M | -$51.23M | -$33.67M | -$31.72M |
| Interest Expense | $2.19M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$151.9M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $2.00M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | -$153.9M | -$37.88M | -$36.90M | -$46.69M | -$63.43M | -$51.03M | -$57.89M | -$48.27M | -$33.28M | -$31.81M |
| Basic EPS | -- | -$59.00 | -$58.00 | -$89.00 | -$123.00 | -$112.00 | -$134.00 | -$118.00 | -$113.00 | -$150.00 |
| Diluted EPS | -- | -$59.00 | -$58.00 | -$89.00 | -$123.00 | -$112.00 | -$134.00 | -$118.00 | -$113.00 | -$150.00 |
| Basic Shares Outstanding | -- | 644.8K | 633.4K | 525.3K | 514.5K | 457.2K | 432.5K | 410.4K | 294.0K | 212.6K |
| Diluted Shares Outstanding | -- | 644.8K | 633.4K | 525.3K | 514.5K | 457.2K | 432.5K | 410.4K | 294.0K | 212.6K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.12M | $0 | $1.04M | $10.84M | $0 | $0 | $0 | $0 |
| Research & Development | $34.30M | $19.39M | $17.90M | $95.03M | $20.35M | $12.08M | $10.63M | $14.03M |
| Total Operating Expenses | $43.02M | $28.13M | $25.77M | $102.3M | $25.89M | $21.03M | $14.22M | $17.19M |
| Operating Income | -$39.91M | -$26.36M | -$24.73M | -$91.49M | -$25.89M | -$21.03M | -$14.22M | -$17.19M |
| EBITDA | -$39.84M | -$26.30M | -$24.66M | -$91.44M | -$25.86M | -$21.03M | -$14.22M | -$17.19M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $1.07M | $1.11M | $852K |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -- | -$17.87M |
| Income Tax Expense | $0 | $0 | $0 | $2.00M | $0 | $0 | $0 | $0 |
| Net Income | -$37.73M | -$24.84M | -$23.28M | -$23.30M | -$24.61M | -$21.79M | -$15.15M | -$17.87M |
| Basic EPS | -- | -- | -- | -- | -- | -- | -$4.00 | -- |
| Basic Shares Outstanding | -- | -- | -- | -- | -- | -- | 645.2K | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $213.2M | $34.77M | $41.79M | $47.87M | $90.25M | $137.0M | $158.2M | $209.9M | $123.9M | $40.04M |
| Cash & Short-Term Investments | $213.2M | $34.77M | $41.79M | $47.87M | $90.25M | $137.0M | $158.2M | $209.9M | $123.9M | $40.04M |
| Accounts Receivable, Net | $18.00M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Current Assets | $5.46M | $38K | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $236.7M | $34.80M | $43.79M | $50.71M | $90.79M | $138.3M | $162.5M | $212.3M | $127.2M | $40.52M |
| Property, Plant & Equipment, Net | $846K | $0 | -- | $242K | $369K | $621K | $823K | $957K | $1.11M | $1.06M |
| Other Non-Current Assets | $1.22M | $813K | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Assets | $3.64M | $813K | $1.53M | $1.10M | $3.56M | $4.56M | $5.44M | $2.57M | $1.36M | $1.87M |
| Total Assets | $240.3M | $35.62M | $45.32M | $51.81M | $94.35M | $142.8M | $168.0M | $214.8M | $128.6M | $42.39M |
| Accounts Payable | -- | $329K | $868K | $970K | $2.11M | $2.09M | $1.44M | $2.66M | $2.65M | $1.57M |
| Deferred Revenue (Current) | $4.16M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | $36.07M | $9.61M | $6.84M | $8.88M | $11.82M | $12.43M | $10.95M | $8.76M | $8.17M | $6.33M |
| Total Non-Current Liabilities | $1.21M | $37.48M | $67K | $0 | $919K | $2.18M | $2.82M | $612K | $707K | $754K |
| Total Liabilities | $37.28M | $47.10M | $6.90M | $8.88M | $12.74M | $14.61M | $13.77M | $9.37M | $8.88M | $7.09M |
| Total Debt (incl. Leases) | $1.64M | $67K | $808K | $919K | $1.92M | $2.82M | $3.62M | -- | -- | -- |
| Common Stock | $28K | $1.0K | $64K | $54K | $52K | $49K | $43K | $43K | $34K | $23K |
| Retained Earnings | -$171.8M | -$17.87M | -$456.5M | -$419.6M | -$372.9M | -$309.5M | -$258.4M | -$200.6M | -$152.3M | -$119.0M |
| Total Stockholders' Equity | $203.0M | -$15.48M | $38.41M | $42.93M | $81.60M | $128.2M | $154.2M | $205.5M | $119.7M | $35.30M |
| Total Equity | $203.0M | -$15.48M | $38.41M | $42.93M | $81.60M | $128.2M | $154.2M | $205.5M | $119.7M | $35.30M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $289.4M | $171.6M | $189.2M | $213.2M | $133.3M | $152.6M | $22.43M | $34.77M |
| Cash & Short-Term Investments | $289.4M | $171.6M | $189.2M | $213.2M | $133.3M | $152.6M | $22.43M | $34.77M |
| Accounts Receivable, Net | $0 | $0 | $0 | $18.00M | -- | -- | -- | $0 |
| Other Current Assets | $5.85M | $7.41M | $6.40M | $5.46M | -- | -- | -- | $38K |
| Total Current Assets | $295.2M | $179.0M | $195.6M | $236.7M | $134.6M | $154.2M | $5.99M | $34.80M |
| Property, Plant & Equipment, Net | $809K | $876K | $929K | $846K | $782K | $193K | -- | $0 |
| Other Non-Current Assets | $984K | $1.50M | $1.16M | $1.22M | $1.25M | $1.30M | -- | $813K |
| Total Non-Current Assets | $4.29M | $3.75M | $3.57M | $3.64M | $3.71M | $3.21M | $0 | $813K |
| Total Assets | $299.5M | $182.8M | $199.1M | $240.3M | $138.3M | $157.4M | $5.99M | $35.62M |
| Accounts Payable | -- | -- | -- | -- | -- | -- | $105K | $329K |
| Deferred Revenue (Current) | $0 | $3.12M | $3.12M | $4.16M | -- | -- | -- | $0 |
| Total Current Liabilities | $23.49M | $18.54M | $14.19M | $36.07M | $20.30M | $16.75M | $2.62M | $9.61M |
| Total Non-Current Liabilities | $1.73M | $966K | $1.09M | $1.21M | $1.32M | $1.43M | $0 | $37.48M |
| Total Liabilities | $25.22M | $19.50M | $15.28M | $37.28M | $21.63M | $18.18M | $2.62M | $47.10M |
| Total Debt (incl. Leases) | $2.46M | $1.44M | $1.54M | $1.64M | $1.74M | $1.64M | -- | $67K |
| Common Stock | $38K | $28K | $28K | $28K | $14K | $14K | $65K | $1.0K |
| Retained Earnings | -$257.7M | -$219.9M | -$195.1M | -$171.8M | -$79.41M | -$54.80M | -$496.7M | -$17.87M |
| Total Stockholders' Equity | $274.3M | $163.3M | $183.8M | $203.0M | $116.6M | $139.3M | -$30.16M | -$15.48M |
| Total Equity | $274.3M | $163.3M | $183.8M | $203.0M | $116.6M | $139.3M | -$30.16M | -$15.48M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$153.9M | -$37.88M | -$36.90M | -$46.69M | -$63.43M | -$51.03M | -$57.89M | -$48.27M | -$33.28M | -$31.81M |
| Depreciation & Amortization | $84K | $35K | $153K | $207K | $265K | $271K | $279K | $275K | $264K | $191K |
| Stock-Based Compensation | $13.30M | $4.70M | $3.52M | $3.86M | $6.09M | $6.90M | $6.22M | $4.59M | $3.76M | $2.96M |
| Change in Receivables | -$18.00M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | -- | -$539K | -$102K | -$1.14M | $18K | $654K | -$1.23M | $16K | $1.06M | $1.00M |
| Operating Cash Flow | -$71.53M | -$31.10M | -$34.88M | -$46.46M | -$57.49M | -$39.24M | -$51.98M | -$43.33M | -$29.77M | -$29.73M |
| Capital Expenditure | -$919K | -$10.0K | -$21K | -$84K | -$15K | -$69K | -$145K | -$126K | -$294K | -$704K |
| Free Cash Flow | -$72.45M | -$31.11M | -$34.90M | -$46.54M | -$57.50M | -$39.31M | -$52.13M | -$43.46M | -$30.06M | -$30.44M |
| Investing Cash Flow | -$72.92M | $20K | -$21K | -$84K | -$15K | -$69K | -$145K | -$126K | -$294K | -$704K |
| Common Stock Issued | $0 | -- | $28.71M | $4.16M | $10.70M | $17.82M | -- | $128.4M | $113.6M | $23.60M |
| Financing Cash Flow | $323.0M | $5.4K | $28.82M | $4.16M | $10.72M | $18.14M | $413K | $129.4M | $113.9M | $23.67M |
| Net Change in Cash | $178.5M | -$31.07M | -$6.08M | -$42.38M | -$46.78M | -$21.17M | -$51.72M | $85.99M | $83.88M | -$6.76M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$37.73M | -$24.84M | -$23.28M | -$23.30M | -$24.61M | -$21.79M | -$2.34M | -$7.22M |
| Depreciation & Amortization | $67K | $66K | $64K | $54K | $28K | $2.0K | $0 | $0 |
| Stock-Based Compensation | $4.22M | $3.96M | $4.11M | $4.75M | $1.99M | $5.34M | $1.23M | $1.13M |
| Change in Receivables | $0 | $0 | $18.00M | -$18.00M | $0 | $0 | $0 | $0 |
| Change in Payables | -- | -- | -- | -- | -- | -- | -$225K | -$252K |
| Operating Cash Flow | -$26.94M | -$19.46M | -$8.94M | -$26.74M | -$17.54M | -$16.40M | -$10.85M | -$6.27M |
| Capital Expenditure | $0 | -$13K | -$147K | -$193K | -$586K | -$140K | $0 | $0 |
| Free Cash Flow | -$26.94M | -$19.48M | -$9.08M | -$26.93M | -$18.12M | -$16.54M | -$10.85M | -$6.27M |
| Investing Cash Flow | $0 | $1.76M | -$8.15M | -$72.19M | -$586K | -$140K | $0 | $0 |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $315K |
| Financing Cash Flow | $144.8M | $136K | -$6.95M | $178.9M | -$1.25M | $146.9M | -$1.49M | $41.03M |
| Net Change in Cash | $117.9M | -$17.57M | -$24.03M | $79.93M | -$19.38M | $130.3M | -$12.34M | $34.77M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1407.5% | -- | -392752.9% | -63204.4% | -5470.7% | -506.8% | -- | -- | -- | -172505.3% |
| Net Profit Margin | -1419.6% | -- | -368994.2% | -62251.7% | -5469.0% | -502.1% | -- | -- | -- | -171945.1% |
| Return on Equity (ROE) | -75.8% | -- | -96.1% | -108.8% | -77.7% | -39.8% | -37.5% | -23.5% | -27.8% | -90.1% |
| Return on Assets (ROA) | -64.1% | -106.4% | -81.4% | -90.1% | -67.2% | -35.7% | -34.5% | -22.5% | -25.9% | -75.0% |
| Current Ratio | 6.56x | 3.62x | 6.41x | 5.71x | 7.68x | 11.13x | 14.84x | 24.22x | 15.56x | 6.40x |
| Quick Ratio | 6.41x | 3.62x | 6.11x | 5.39x | 7.63x | 11.03x | 14.45x | 23.95x | 15.16x | 6.32x |
| Debt to Equity | 0.01x | -- | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | -- | -- | -- |
| Revenue Growth (YoY) | -- | -- | -86.7% | -93.5% | -88.6% | -- | -- | -- | -- | -99.9% |
| 5Y Revenue / Share Growth | -- | -- | -- | -- | +2489.8% | -78.9% | -- | -- | -- | -- |
| 10Y Revenue / Share Growth | -- | -- | -100.0% | -100.0% | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -- | -- | -108.6% | -- |
| 10Y Net Income / Share Growth | -- | -- | -- | -106.8% | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1216.6% | -1417.7% | -1372.9% | -1407.5% | -- | -- | -- | -- |
| Net Profit Margin | -727.6% | -808.1% | -782.5% | -782.4% | -- | -- | -- | -- |
| Return on Equity (ROE) | -39.8% | -58.8% | -50.6% | -41.8% | -68.1% | -46.4% | -- | -- |
| Return on Assets (ROA) | -36.4% | -52.5% | -46.7% | -35.3% | -57.4% | -41.1% | -883.4% | -136.2% |
| Current Ratio | 12.57x | 9.66x | 13.78x | 6.56x | 6.63x | 9.21x | 2.29x | 3.62x |
| Quick Ratio | 12.32x | 9.26x | 13.33x | 6.41x | 6.56x | 9.12x | 8.57x | 3.62x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | -- | -- |